PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions. (Q51219604)

1 April 2018

title

PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions. (English)

1 reference

1 April 2018

chronic lymphocytic leukemia

main subject

lymphocyte

0 references

1 reference

Y-J Li

1

1 reference

1 April 2018

L Sun

2

1 reference

1 April 2018

Y Shi

3

1 reference

1 April 2018

G Wang

4

1 reference

1 April 2018

X Wang

5

1 reference

1 April 2018

S E Dunn

6

1 reference

1 April 2018

C Iorio

7

1 reference

1 April 2018

R A Screaton

8

1 reference

1 April 2018

D E Spaner

9

1 reference

1 April 2018

publication date

4 January 2017

1 reference

1 April 2018

published in

Leukemia

1 reference

1 April 2018

volume

31

1 reference

1 April 2018

issue

9

1 reference

1 April 2018

page(s)

1905-1914

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1038/leu.2016.395

exact match

0 references

cites work

New strategies in chronic lymphocytic leukemia: shifting treatment paradigms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPARs and lipid ligands in inflammation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

AMPK and PPARdelta agonists are exercise mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

ONCOMINE: a cancer microarray database and integrated data-mining platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Identification of progression markers in B-CLL by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Karyotype-specific microRNA signature in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Is miR-29 an oncogene or tumor suppressor in CLL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Tissue culture as a hostile environment: identifying conditions for breast cancer progression studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Oxidative stress in cell culture: an under-appreciated problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

MicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

The Dual Roles of NRF2 in Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Transcriptional network governing the angiogenic switch in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

High-fat diet enhances stemness and tumorigenicity of intestinal progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Peroxisome proliferator-activated receptor δ promotes colonic inflammation and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

PPARδ, but not PPARα, activates PGC-1α gene transcription in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

A role for oleoylethanolamide in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Neuroprotective actions of dipyridamole on cultured CNS neurons.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

The antioxidant functions of cytochrome c

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

CLL: a supplementary question?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.395

7 January 2021

Identifiers

DOI

10.1038/LEU.2016.395

1 reference

1 April 2018

Dimensions Publication ID

1017693290

0 references

1 reference

1 April 2018